BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-1.19%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$632M
AUM Growth
+$632M
(+5.4%)
Cap. Flow
+$56.5M
Cap. Flow
% of AUM
8.94%
Top 10 Holdings %
Top 10 Hldgs %
85.21%
Holding
32
New
4
Increased
11
Reduced
4
Closed
2
Top Buys
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$28.4M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$19.6M |
| 3 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$6.44M |
| 4 |
Cytokinetics
CYTK
|
$5.79M |
| 5 |
TRVN
Trevena, Inc.
TRVN
|
$4.34M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$12.7M |
| 2 |
Rigel Pharmaceuticals
RIGL
|
$10M |
| 3 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$3.82M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$1.44M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$1.43M |
Sector Composition
| 1 | Healthcare | 76.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VXRT
26
DELISTED
Vaxart
VXRT
| $1.24M | 0.2% |
39,627
| – | – |
|
|
PRTK
27
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $299K | 0.05% |
12,500
| – | – |
|
28
Amgen
AMGN
$153B
| – | – |
0
| – | – |
|
|
29
Rigel Pharmaceuticals
RIGL
$710M
| – | – |
-257,671
| Closed | -$10M |
|
|
MRTX
30
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-74,900
| Closed | -$1.43M |
|